Pediatric Drugs: Efcacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double‑Blind, Placebo‑Controlled Study by NCIM Team | Nov 16, 2022 | SIH - Membership, SIH - Research Username ?> Password ?> Remember Me Forgot Password